Back to Browse Journals

Research and Reports in Urology


Dr Colli

Department of Urology, Veterans Administration Hospital, United States

Dr Colli

Editor-in-Chief: Dr Janet Colli

Dr Colli specializes in Urologic Oncology and Robotic Surgery at Urology Specialists of West Florida. Prior to this she was Assistant Professor in Surgery at the University of Alabama at Birmingham Medical Center. Dr Colli specializes in diagnostic and therapeutic aspects of urologic malignancies, has extensive expertise in multimodal approaches to complex problems and has a strong research interest in developmental therapeutics for prostate cancer and other malignancies including bladder and kidney cancer. She also has expertise in Urologic Reconstruction & Trauma. She has extensive experience in bladder replacement/augmentation, repair of urinary fistulas, urethral strictures, and ureteral reconstruction.

Dr Colli trained as a Urologist at West Virginia University, and then completed a sub-specialty fellowship in Urologic Oncology at the University of Washington in Seattle. Her research interests include epidemiology of urologic disease, prostate, kidney and bladder cancer outcomes, including prostate, kidney and bladder cancer screening, and outcomes of urologic surgery & treatments. Additional interests include identification of bio-markers for prostate, kidney and bladder cancer to aid in early detection of diseases. She has published extensively and is widely known for her work in epidemiology and the identification of risk factors in urologic malignancies.

Her research interests include epidemiology of urologic disease, prostate, kidney and bladder cancer outcomes, including prostate, kidney and bladder cancer screening, and outcomes of urologic surgery & treatments. Additional interests include identification of bio-markers for prostate, kidney and bladder cancer to aid in early detection of diseases. She has published extensively and is widely known for her work in epidemiology and the identification of risk factors in urologic malignancies.


Editorial Board

Medhat Abdalla, Department of Urology, Assuit University Medical School, Assuit, Egypt

Kazem Azadzoi, Professor, Departments of Surgery and Urology, Boston University Medical School, Boston, MA, USA

Aristotelis Bamias, Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece

Jens Ceder, Department of Translational Medicine, Division of Urology, Lund University, Malmö, Sweden

Boris Chertin, Professor and Chairman, The Department of Pediatric Urology, Shaare Zedek Medical Center, Jerusalem, Israel

Piergiuseppe Colombo, Vice-Director, Department of Pathology, University of Milan School of Medicine, Humanitas Clinical Institute, Rozzano, Milan

Roger Roman Dmochowski, Professor, Department of Urology, Vanderbilt University, Nashville, TN, USA

Oliver Hakenberg, Professor, Department of Urology Rostock University Germany

Mamdouh M. Koraitim, Professor, Department of Urology, College of Medicine, University of Alexandria, Alexandria, Egypt

Gianni Paulis, Urologist, Andrologist and Director of Andrology Center at Regina Apostolorum Hospital (Albano L.-Rome, Italy) and Peyronie’s Care Center (Rome, Italy)

Prem Puri, Professor, National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland

Paul J. Scheel, Director, Division of Nephrology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Ajay Singla, Professor and Vice Chair, Director, Urology Residency Program and Female Pelvic Medicine & Reconstructive Surgery, Department of Urology, University of Toledo College of Medicine, Toledo, Ohio, USA

David Waltregny, Professor, Department of Urology, Centre Hospitalier Universitaire du Sart Tilman, Liege, Belgium

Stefan Zastrow, Department of Urology, University of Dresden, Dresden, Germany